Tactile Systems Technology (Tactile Systems Technology) Operating Income : $15.5 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Tactile Systems Technology Operating Income?

Tactile Systems Technology's Operating Income for the three months ended in Dec. 2023 was $12.4 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $15.5 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Tactile Systems Technology's Operating Income for the three months ended in Dec. 2023 was $12.4 Mil. Tactile Systems Technology's Revenue for the three months ended in Dec. 2023 was $77.7 Mil. Therefore, Tactile Systems Technology's Operating Margin % for the quarter that ended in Dec. 2023 was 15.91%.

Tactile Systems Technology's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Tactile Systems Technology's annualized ROC % for the quarter that ended in Dec. 2023 was 19.12%. Tactile Systems Technology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 84.59%.

Tactile Systems Technology Operating Income Historical Data

The historical data trend for Tactile Systems Technology's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tactile Systems Technology Operating Income Chart

Tactile Systems Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Income

Get a 7-Day Free Trial

10.50

-3.63

-1.76

-12.76

18.04

Tactile Systems Technology Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Income	Get a 7-Day Free Trial															7.85	-3.81	2.06	4.92	12.36

Tactile Systems Technology Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.5 Mil.

Tactile Systems Technology (NAS:TCMD) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Tactile Systems Technology's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	49.428 * ( 1 - 30.28% )	/	( (185.063	+	175.391)	/ 2 )
=	34.4612016	/	180.227
=	19.12 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	293.307	-	28.605	-	( 79.639	-	max(0, 45.618	-	151.69	+	79.639	))
=	185.063

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	281.438	-	30.819	-	( 75.228	-	max(0, 41.057	-	145.294	+	75.228	))
=	175.391

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Tactile Systems Technology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	49.428	/	( ( (24.789 + max(31.985, 0))	+	(25.323 + max(34.772, 0)) )	/	2 )
=	49.428	/	( ( 56.774	+	60.095 )	/	2 )
=	49.428	/	58.4345
=	84.59 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(43.879	+	23.498	+	4.674)	-	(28.605	+	0	+	11.461)
=	31.985

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(43.173	+	22.527	+	4.366)	-	(30.819	+	0	+	4.475)
=	34.772

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Tactile Systems Technology's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %	=	Operating Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	12.357	/	77.652
	=	15.91 %

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Tactile Systems Technology Operating Income Related Terms

Thank you for viewing the detailed overview of Tactile Systems Technology's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Tactile Systems Technology (Tactile Systems Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tactile Systems Technology Inc (NAS:TCMD) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

3L3:Germany

Address

3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416

Website

https://www.tactilemedical.com

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Executives

Boyd Vindell Washington	director	1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
Daniel L. Reuvers	director, officer: President and CEO	INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Sherri Lee Ferstler	officer: Senior VP, Sales	1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
William W Burke	director	3868 MOCKINGBIRD LN, DALLAS TX 75205
Kristie Burns	officer: Sr. VP Mktg & Clinical Affairs	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Eric Pauls	officer: Senior VP, Sales	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Elaine M. Birkemeyer	officer: Chief Financial Officer	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Brent Moen	officer: Chief Financial Officer	3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447
Carmen B Volkart	director	C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Valerie L. Asbury	director	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
David Brent Shafer	director	2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Bryan Rishe	officer: Vice President, Sales	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Deepti Jain	director	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sheri Louise Dodd	director	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Gerald R. Mattys	director, officer: Chief Executive Officer	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413